Tabletop Fire Pit Lawsuit Individuals who suffered severe burns, or families who lost a loved one in a tabletop fire pit explosion, may be eligible for financial compensation through a fire pit injury lawsuit.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Change Healthcare Lawsuit Lawyers are reviewing Change Healthcare class action lawsuits for individuals who had their personal information stolen due to the data breach.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
AngioDynamics Port Catheter Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
9 out of 10 Sports Supplements Fail to Accurately List Ingredients on the Label: Study Researchers indicate that sports dietary supplements are more likely to contained banned substances than they are to accurately list ingredients on the label. July 25, 2023 Irvin Jackson Add Your Comments Nearly 90% of dietary supplements marketed to enhance sports performance fail to accurately list ingredients on their label, according to the findings of a new study, which indicates that many actually contain substances which pose serious health risks for users. In a report published this month in the medical journal JAMA Network Open, Harvard researchers warn that, in addition to failing to accurately list their ingredients, many sports supplements contain ingredients that are prohibited by the Food and Drug Administration (FDA), including banned stimulants like 1,4-dimethylamylamine or 1,4-DMM. Researchers studied 57 dietary supplement products and tested them to determine if they contained the ingredients listed on the label. Each supplement chosen for the study contained one of the following ingredients: Rauwolfia vomitoria, methylliberine, turkesterone, halostachine, or octapamine. The supplements were purchased online, and then analyzed for the presence and quantity of the five ingredients as well as FDA-prohibited ingredients. The products tested were marketed as sports supplements, including stimulant or anabolic effects, which were intended to enhance athletic performance in some way. Dietary Supplement Labels Often Inaccurate Of the 57 products analyzed, 89% did not accurately list ingredients on the label, with 40% not even containing any detectable amount of the ingredients that were disclosed. Among the products that contained ingredients listed on the label, the amount of the ingredients in the product ranged from 0.02% to 334% of the labeled quantity. Only 11% of products accurately listed their ingredients, coming within 10% of the amounts listed on the label. However, 12%, were found to contain at least one ingredient that was banned by the FDA or other regulatory agencies. Five different FDA-banned compounds were detected in the supplements, including four synthetic ingredients, 1,4-dimethylamylamine, deterenol, octodrine, oxilofrine, and omberacetam. Six of the tested products contained one of the banned ingredients, and one contained four of the banned ingredients. Those ingredients are banned for a number of reasons. For example 1,4-DMM can lead to cardiac arrest, stroke, and death. Deterenol can cause mild to severe symptoms, from nausea to cardiac arrest. Octodrine can lead to high blood pressure, energy crashes, rapid heartbeat, and tremors. Oxilofrine can cause vomiting, agitation, and heart problems, while omberacetam can result in depression, anxiety, and sleep problems. Dietary Supplement Regulations Prior reports have raised similar concerns about harmful ingredients in dietary supplements, which are not approved or considered safe by the FDA. A 2018 study found nearly 800 over-the-counter supplements contained unapproved active ingredients. The FDA does not specifically approve individual dietary supplements introduced for sale in the U.S., and does not conduct oversight to test products for safety or effectiveness once they are on the market. However, the FDA does conduct periodic inspections of some supplements, and those inspections typically identify a surprising number of companies that fail to comply with good manufacturing standards related to the purity or composition of the supplements. Do You Know about… SPORTS BETTING ADDICTION LAWSUITS FOR YOUNG ADULTS Gambling addiction and severe financial losses have been linked to popular sports betting platforms like DraftKings, FanDuel, and Caesars. Lawsuits are being filed by young adults and students who were targeted by deceptive promotions, addictive app features, and aggressive marketing tactics. See if you qualify for a sports betting addiction lawsuit. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Do You Know About… SPORTS BETTING ADDICTION LAWSUITS FOR YOUNG ADULTS Gambling addiction and severe financial losses have been linked to popular sports betting platforms like DraftKings, FanDuel, and Caesars. Lawsuits are being filed by young adults and students who were targeted by deceptive promotions, addictive app features, and aggressive marketing tactics. See if you qualify for a sports betting addiction lawsuit. Learn More SEE IF YOU QUALIFY FOR COMPENSATION The FDA issued a proposal in 2022 to allow manufacturers to submit late safety data for dietary supplements, even if there are new ingredients they previously failed to report as required by law. The proposal would help to increase agency oversight of an industry that is largely unregulated. However, the market for dietary supplements continues to expand at a rapid pace, despite prior research indicating most supplements have little benefit to human health. The researchers of this latest study recommend doctors warn consumers about the risks some supplements pose. Warnings should highlight that fitness supplements with advertised stimulants or anabolic effects may not be accurately labeled, may contain more of one ingredient or less of another, and may often contain banned ingredients that may have harmful side effects. Tags: Dietary Supplements, Drug Side Effects, False Advertising, Food Labeling Written by: Irvin Jackson Senior Legal Journalist & Contributing Editor Irvin Jackson is a senior investigative reporter at AboutLawsuits.com with more than 30 years of experience covering mass tort litigation, environmental policy, and consumer safety. He previously served as Associate Editor at Inside the EPA and contributes original reporting on product liability lawsuits, regulatory failures, and nationwide litigation trends. More Lawsuit Stories Lawsuit Claims Cartiva Implant Caused Bone Loss and Nerve Damage in Big Toe August 12, 2025 Paraquat MDL Lawsuit Deadlines Extended Again, as Settlement Details Finalized August 12, 2025 New Report Tracks Baby Food Heavy Metal Testing, Transparency August 12, 2025 0 Comments Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermEmailThis field is for validation purposes and should be left unchanged. Δ MORE TOP STORIES Lawsuit Claims Cartiva Implant Caused Bone Loss and Nerve Damage in Big Toe (Posted: today) A Cartiva implant lawsuit blames the manufacturer for failing to warn patients about high failure rates for years after it began receiving implant complication reports. MORE ABOUT: CARTIVA IMPLANT LAWSUITJudge Orders Cartiva Implant Settlement Talks Before Trial in Aug. 2026 (07/28/2025)Cartiva Settlement Rumors Mount Again, as More Toe Implant Lawsuits Withdrawn and Trials Approach (06/26/2025)Failed Cartiva Implant Resulted in Need for Removal, Big Toe Fusion Surgery: Lawsuit (04/10/2025) Nearly 200 Women Pursuing BioZorb Lawsuits Over Complications With Breast Tissue Marker (Posted: yesterday) Hologic faces at least 183 BioZorb lawsuits, a number which continues to grow as the first bellwether trial is pushed back to January 2026. MORE ABOUT: BIOZORB LAWSUITFailed BioZorb Tissue Marker to Require Surgical Removal, Lawsuit Claims (08/04/2025)Problems With BioZorb Tissue Markers Not Adequately Disclosed by Manufacturer: Lawsuit (07/28/2025)Lawyers Preparing BioZorb Lawsuit To Go Before Jury on Sept. 8, 2025 (07/23/2025) Chemo Port Infection Lawsuits Over Bard, AngioDynamics Catheters Allege Faulty Design Promotes Bacterial Growth (Posted: 4 days ago) Lawsuits against Bard and AngioDynamics have been consolidated in separate MDLs, alleging that design defects in their implantable port catheter systems caused severe infections that were not properly disclosed. MORE ABOUT: BARD POWERPORT LAWSUITBard PowerPort Infection Lawsuit Chosen for First Bellwether Trial in Feb. 2026 (07/18/2025)Cook Medical Angiographic Catheter Recall Issued Following Multiple Reports of Serious Injury: FDA (06/27/2025)More Than 1,700 Bard PowerPort Lawsuits Now Filed in State and Federal Courts (06/03/2025)
Lawsuit Claims Cartiva Implant Caused Bone Loss and Nerve Damage in Big Toe (Posted: today) A Cartiva implant lawsuit blames the manufacturer for failing to warn patients about high failure rates for years after it began receiving implant complication reports. MORE ABOUT: CARTIVA IMPLANT LAWSUITJudge Orders Cartiva Implant Settlement Talks Before Trial in Aug. 2026 (07/28/2025)Cartiva Settlement Rumors Mount Again, as More Toe Implant Lawsuits Withdrawn and Trials Approach (06/26/2025)Failed Cartiva Implant Resulted in Need for Removal, Big Toe Fusion Surgery: Lawsuit (04/10/2025)
Nearly 200 Women Pursuing BioZorb Lawsuits Over Complications With Breast Tissue Marker (Posted: yesterday) Hologic faces at least 183 BioZorb lawsuits, a number which continues to grow as the first bellwether trial is pushed back to January 2026. MORE ABOUT: BIOZORB LAWSUITFailed BioZorb Tissue Marker to Require Surgical Removal, Lawsuit Claims (08/04/2025)Problems With BioZorb Tissue Markers Not Adequately Disclosed by Manufacturer: Lawsuit (07/28/2025)Lawyers Preparing BioZorb Lawsuit To Go Before Jury on Sept. 8, 2025 (07/23/2025)
Chemo Port Infection Lawsuits Over Bard, AngioDynamics Catheters Allege Faulty Design Promotes Bacterial Growth (Posted: 4 days ago) Lawsuits against Bard and AngioDynamics have been consolidated in separate MDLs, alleging that design defects in their implantable port catheter systems caused severe infections that were not properly disclosed. MORE ABOUT: BARD POWERPORT LAWSUITBard PowerPort Infection Lawsuit Chosen for First Bellwether Trial in Feb. 2026 (07/18/2025)Cook Medical Angiographic Catheter Recall Issued Following Multiple Reports of Serious Injury: FDA (06/27/2025)More Than 1,700 Bard PowerPort Lawsuits Now Filed in State and Federal Courts (06/03/2025)